ATLAS CAPITAL ADVISORS LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.

Quarter-by-quarter ownership
ATLAS CAPITAL ADVISORS LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$15,700
-39.1%
5,0000.0%0.00%
-25.0%
Q2 2023$25,800
-2.1%
5,0000.0%0.00%0.0%
Q1 2023$26,350
+87.5%
5,0000.0%0.00%
+100.0%
Q4 2022$14,050
-99.9%
5,0000.0%0.00%
-50.0%
Q3 2022$20,750,000
+3.2%
5,0000.0%0.00%
+33.3%
Q2 2022$20,100,000
-18.8%
5,0000.0%0.00%
-25.0%
Q1 2022$24,750,000
-29.0%
5,0000.0%0.00%
-20.0%
Q4 2021$34,850,000
-30.3%
5,0000.0%0.01%
-37.5%
Q3 2021$50,000,000
-29.5%
5,0000.0%0.01%
-33.3%
Q2 2021$70,900,000
-13.6%
5,0000.0%0.01%
-25.0%
Q1 2021$82,050,000
-20.7%
5,0000.0%0.02%
-27.3%
Q4 2020$103,500,000
+148.5%
5,0000.0%0.02%
+120.0%
Q2 2020$41,650,000
+68.3%
5,0000.0%0.01%
+42.9%
Q1 2020$24,750,000
+25.3%
5,0000.0%0.01%
+40.0%
Q4 2019$19,750,000
+29.9%
5,0000.0%0.01%0.0%
Q3 2019$15,200,000
-30.9%
5,0000.0%0.01%
-28.6%
Q2 2019$22,000,000
+10.8%
5,0000.0%0.01%0.0%
Q1 2019$19,850,000
-0.3%
5,0000.0%0.01%
-12.5%
Q4 2018$19,900,0005,0000.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
UBS OCONNOR LLC 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders